Where Human Insight Meets Artificial Intelligence

One company that uses AI where it truly moves the needle is Evotec, a global drug discovery and development partner headquartered in the heart of Europe, in Hamburg. The company’s integration of computation, biology, and experimental design is driving drug discovery workflows where algorithms and seasoned drug developers push each other forward.

Evotec offers fully end to end drug discovery and development capabilities – from target identification and validation to hit identification, lead optimization, IND preparation, early clinical development, and Phase I-III support. Its platforms span highthroughput screening, multiomics technologies, and advanced in silico design.

The company has a strong track record of progressing drugs to the clinic and the market, and strong technological capabilities. Leaders at Evotec argue that the real frontier of the business is not algorithms alone, but the way their experienced drug developers weave AI into their processes.